Navigation Links
Avantra Biosciences Offers Its Proprietary PATH® Slides for Sale
Date:3/22/2011

WOBURN, Mass., March 22, 2011 /PRNewswire/ -- Avantra Biosciences has announced they are selling their new and improved proprietary PATH® Protein Microarray Ultra-thin Nitrocellulose Slides. Additionally, Avantra is discussing the possibility of partnering with certain parties to expand the distribution network for the PATH slides.

The PATH Slide is the first protein microarray slide to provide the many benefits of nitrocellulose in a thin film that allows very low background fluorescence and excellent signal-to-noise ratio.

"Nitrocellulose has proven to be the protein-assay substrate of choice for decades. With this technology, researchers can use a wide variety of fluorescence probes to make protein assays easier, faster and more sensitive than ever before," said Brendan McKernan, President of Avantra Biosciences. "By delivering a high signal-to-noise ratio and low background fluorescence, we believe the PATH surface chemistry to be far superior to other commercially available protein-array surfaces."

Key Features:

  • Excellent stability and shelf life

  • Best in class sensitivity, accuracy, and reproducibility and dynamic range providing excellent spot morphology, retained protein conformation and functional activity.

  • Low background and increased dynamic range – proprietary ultra-thin nitrocellulose provides enhances signal-to-noise ratios

  • Standard slide format – adaptable to all commonly used slide format microarray readers

Ordering information
Email: sales@avantrabio.com
Phone: 877.395.7608
Fax: 617.892.7191

About Avantra Biosciences Corporation

Avantra Biosciences is a privately held diagnostics company that has pioneered next generation technology for protein biomarker analysis.  The PATH technology is integrated into the Avantra Q400 Biomarker Workstation.  Avantra's integrated system enables scientists and clinicians to perform multiplex biomarker analysis for research use only (RUO) from their lab bench or clinical trial site.

www.AvantraBio.com

Copyright © 2011 Avantra Biosciences Corporation. All rights reserved.


'/>"/>
SOURCE Avantra Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results
2. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
3. Ardea Biosciences Announces Exercise in Full of Overallotment Option for Common Stock Offering
4. Swift Biosciences Presents Highly Sensitive, Highly Specific qPCR Mutation Detection Data at 18th International Molecular Medicine Tri-Conference
5. Martek Biosciences Inducted into Small Business Innovation Research (SBIR) Hall of Fame
6. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
7. YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results
8. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
9. Sangamo BioSciences Announces Fourth Quarter and Full Year 2010 Conference Call and Webcast
10. YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium
11. Ardea Biosciences Prices Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
Breaking Biology Technology:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:5/24/2016)... Calif. , May 24, 2016 Ampronix facilitates superior patient care by ... LMD3251MT  3D medical LCD display is the latest premium product recently added to the ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):